The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.07BCNY
904.72M · vs all stocks (USD)
Updated Sep 19, 2026
Revenue (TTM)
10.34BCNY
1.54B · vs all stocks (USD)
Updated Sep 19, 2026
Profit Margin
-26.11%
Updated Sep 19, 2026
52-Week Change
-24.58%
vs all stocks
Updated Sep 19, 2026
Market Capitalization
6.07BCNY
904.72M · vs all stocks (USD)
Updated Sep 19, 2026
Enterprise Value
27.62BCNY
4.12B · vs all stocks (USD)
Updated Sep 19, 2026
Forward P/E
6.59x
Updated Sep 19, 2026
Price to Sales (TTM)
0.5866x
Updated Sep 19, 2026
Price to Book (MRQ)
0.8819x
Updated Sep 19, 2026
Enterprise to Revenue
2.11x
Provider-reported. Enterprise Value ÷ Revenue (TTM) on this page gives 2.67×.Updated Sep 19, 2026
Enterprise to EBITDA
12.44x
Updated Sep 19, 2026
Gross Margin
15.56%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 10.33%.Updated Sep 19, 2026
Profit Margin
-26.11%
Updated Sep 19, 2026
Operating Margin
-0.10%
Updated Sep 19, 2026
Return on Assets (TTM)
-3.29%
Updated Sep 19, 2026
Return on Equity (TTM)
-17.51%
Updated Sep 19, 2026
Revenue (TTM)
10.34BCNY
1.54B · vs all stocks (USD)
Updated Sep 19, 2026
Revenue per Share (TTM)
4.13CNYUpdated Sep 19, 2026
Quarterly Revenue Growth
-1.70%
Updated Sep 19, 2026
Gross Profit (TTM)
1.07BCNY
159.33M · vs all stocks (USD)
Updated Sep 19, 2026
EBITDA (TTM)
2.22BCNY
331.25M · vs all stocks (USD)
Updated Sep 19, 2026
Net Income (TTM)
-2.70BCNY
-402.78M · vs all stocks (USD)
Updated Sep 19, 2026
Quarterly Earnings Growth (YoY)
-58.34%
Updated Sep 19, 2026
Operating Cash Flow (TTM)
4.81BCNY
717.56M · vs all stocks (USD)
Updated Sep 19, 2026
Levered Free Cash Flow (TTM)
-1.97BCNY
-293.84M · vs all stocks (USD)
Updated Sep 19, 2026
Payout Ratio
0.00%
Updated Sep 19, 2026
Minority Interest (Equity)
7.10BCNYFY2025 · Dec 31, 2025
Revenue
13.06BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
10.34BCNYFY2025 · Dec 31, 2025
Gross Profit
2.72BCNYFY2025 · Dec 31, 2025
Operating Income
1.36BCNY
202.32M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-1.42BCNYFY2025 · Dec 31, 2025
Income Tax Expense
470.79MCNYFY2025 · Dec 31, 2025
Net Income
-1.89BCNYFY2025 · Dec 31, 2025
EBIT
-528.52MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
2.22BCNYFY2025 · Dec 31, 2025
Research & Development
74.23MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
298.88MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
439.08MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
72.10MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
895.40MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.7300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.7300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.70BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.70BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-1.89BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-75.27MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
6.95BCNYFY2025 · Dec 31, 2025
Free Cash Flow
5.51BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
7.56BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-1.89BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
929.82MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
1.45BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
6.47BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-1.44BCNYFY2025 · Dec 31, 2025
Net Acquisitions
454.98MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-154.03MCNYFY2025 · Dec 31, 2025
Sale of Investments
43.52MCNYFY2025 · Dec 31, 2025
Other Investing Activity
228.88MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-865.25MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
9.51BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-11.75BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-881.74MCNYFY2025 · Dec 31, 2025
Other Financing Charges
697.47MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-2.43BCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.71BSharesUpdated Sep 19, 2026
Float Shares
825.29MSharesUpdated Sep 19, 2026
% Held by Insiders
69.72%
vs all stocks
Updated Sep 19, 2026
% Held by Institutions
1.13%
vs all stocks
Updated Sep 19, 2026
Total Cash (MRQ)
4.48BCNY
668.93M · vs all stocks (USD)
Updated Sep 19, 2026
Total Debt (MRQ)
27.45BCNY
4.09B · vs all stocks (USD)
Updated Sep 19, 2026
Total Debt to Equity (MRQ)
2.21x
Updated Sep 19, 2026
Current Ratio (MRQ)
1.22x
Updated Sep 19, 2026
Book Value per Share (MRQ)
2.54CNYUpdated Sep 19, 2026
Total Assets
59.89BCNY
8.93B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
25.27BCNYFY2025 · Dec 31, 2025
Total Liabilities
45.91BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
34.62BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
25.05BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
20.87BCNYFY2025 · Dec 31, 2025
Cash
3.21BCNYFY2025 · Dec 31, 2025
Cash Equivalents
4.42BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
7.63BCNYFY2025 · Dec 31, 2025
Accounts Receivable
603.12MCNYFY2025 · Dec 31, 2025
Inventory
12.20BCNYFY2025 · Dec 31, 2025
Accounts Payable
3.08BCNYFY2025 · Dec 31, 2025
Short-term Debt
7.84BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.77BCNYFY2025 · Dec 31, 2025
Long-term Debt
21.33BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.08BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.71BCNYFY2025 · Dec 31, 2025
Retained Earnings
1.54BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
13.98BCNY
2.08B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
0.00CNYFY2025 · Dec 31, 2025
52-Week Low
1.91CNYUpdated Sep 19, 2026
52-Week High
3.45CNYUpdated Sep 19, 2026
52-Week Change
-24.58%
vs all stocks
Updated Sep 19, 2026
50-Day MA
2.14CNYUpdated Sep 19, 2026
200-Day MA
2.46CNYUpdated Sep 19, 2026
Avg 10-Day Volume
19.91MSharesUpdated Sep 19, 2026
Avg 30-Day Volume
23.73MSharesUpdated Sep 19, 2026
Diluted EPS (TTM)
-1.00CNYUpdated Sep 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.39: distress zoneCritical
Altman Z-Score: 0.39
High earnings qualityNotable
Earnings Quality Score: 0.77
Supply Chain
Upstream position: supplies 7 industries, depends on 1Notable
Outgoing: 7.00Incoming: 1.00
Scale
Levered free cash flow is -$293.84M, lower than 95% of all stocks globallySignificant